Skip to main content
Erschienen in: Pediatric Cardiology 7/2017

21.06.2017 | Original Article

Safety, Feasibility, Results, and Economic Impact of Common Interventional Procedures in a Low-Volume Region of the United States

verfasst von: Aaron Clem, Sami Awadallah, Zahid Amin

Erschienen in: Pediatric Cardiology | Ausgabe 7/2017

Einloggen, um Zugang zu erhalten

Abstract

The aim of the study was to evaluate the safety, feasibility, and economic benefit of a high-volume operator performing common interventional procedures in a rural region of the United States (U.S.). Rural areas of the U.S., even with well-equipped cardiac catheterization laboratories, may not have a full-time pediatric interventional cardiologist (PIC); this requires patients to travel out of state even for simple interventions. Since 2005, we have adopted a policy of performing cardiac catheterizations and common interventional procedures with a visiting PIC. We reviewed data of all patients who underwent cardiac catheterizations from May 2005 through March 2015 at our center. Variables analyzed were type of procedure, results, and follow-up six months after procedure. 197 catheterizations were performed, of which 80 were for single atrial septal defect (ASD), 29 for fenestrated ASD, 49 for patent ductus arteriosus (PDA), and 39 for other procedures. Device closure of single ASD was successful in 75 of 79 attempts and in 27 of 28 attempts for fenestrated ASD. PDA closure was successful in 45 of 46 attempts. Follow-up data of 6 months or more were available for 127 patients. All but two patients had no cardiovascular symptoms at 6 months. There were four minor complications and no major complications. With a technical success rate of 94.9% for single ASD closure, 97.8% for PDA closure, and results comparable to those of multi-institutional registries, cardiac catheterization and interventions can be performed safely with excellent results. Performing procedures in such an arrangement is safe, feasible, and economically beneficial.
Literatur
1.
Zurück zum Zitat Everett AD, Jennings J, Sibinga E, Owada C, Lim DS et al (2009) Community use of the Amplatzer atrial septal defect occluder: results of the multicenter magic atrial septal defect study. Pediatr Cardiol 30:240–247CrossRefPubMed Everett AD, Jennings J, Sibinga E, Owada C, Lim DS et al (2009) Community use of the Amplatzer atrial septal defect occluder: results of the multicenter magic atrial septal defect study. Pediatr Cardiol 30:240–247CrossRefPubMed
2.
Zurück zum Zitat El-Said HG, Hegde S, Foerster S, Hellenbrand W, Kreutzer J et al (2015) Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events. Catheter Cardiovasc Interv 85:227–233CrossRefPubMed El-Said HG, Hegde S, Foerster S, Hellenbrand W, Kreutzer J et al (2015) Device therapy for atrial septal defects in a multicenter cohort: acute outcomes and adverse events. Catheter Cardiovasc Interv 85:227–233CrossRefPubMed
3.
Zurück zum Zitat El-Said HG, Bratincsak A, Foerster SR, Murphy JJ, Vincent J et al (2013) Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience. J Am Heart Assoc 2(6):e000424CrossRefPubMedPubMedCentral El-Said HG, Bratincsak A, Foerster SR, Murphy JJ, Vincent J et al (2013) Safety of percutaneous patent ductus arteriosus closure: an unselected multicenter population experience. J Am Heart Assoc 2(6):e000424CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE (2004) Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. JACC 44(3):513–519CrossRefPubMed Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE (2004) Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. JACC 44(3):513–519CrossRefPubMed
5.
Zurück zum Zitat Holzer RJ, Gauvreau K, Kreutzer J, Trucco SM, Torres A et al (2012) Safety and efficacy of balloon pulmonary valvuloplasty: a multicenter experience. Catheter Cardiovasc Interv 80(4):663–672CrossRefPubMed Holzer RJ, Gauvreau K, Kreutzer J, Trucco SM, Torres A et al (2012) Safety and efficacy of balloon pulmonary valvuloplasty: a multicenter experience. Catheter Cardiovasc Interv 80(4):663–672CrossRefPubMed
6.
Zurück zum Zitat Torres A, Vincent JA, Everett A, Lim S, Foerster SR et al (2015) Balloon valvuloplasty for congenital aortic stenosis: multi-center safety and efficacy outcome assessment. Catheter Cardiovasc Interv 86(5):808–820CrossRefPubMed Torres A, Vincent JA, Everett A, Lim S, Foerster SR et al (2015) Balloon valvuloplasty for congenital aortic stenosis: multi-center safety and efficacy outcome assessment. Catheter Cardiovasc Interv 86(5):808–820CrossRefPubMed
7.
Zurück zum Zitat Moore JW, Vincent RN, Beekman RH, Benson L, Bergersen L et al (2014) Procedural results and safety of common interventional procedures in congenital heart disease. JACC 64(23):2439–2451CrossRefPubMed Moore JW, Vincent RN, Beekman RH, Benson L, Bergersen L et al (2014) Procedural results and safety of common interventional procedures in congenital heart disease. JACC 64(23):2439–2451CrossRefPubMed
8.
Zurück zum Zitat Levi DS, Moore JW (2004) Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv 61:543–547CrossRefPubMed Levi DS, Moore JW (2004) Embolization and retrieval of the Amplatzer septal occluder. Catheter Cardiovasc Interv 61:543–547CrossRefPubMed
9.
Zurück zum Zitat Knott-Craig CJ, Goldberg SP (2008) Emergent surgical retrieval of embolized atrial septal defect closure device. Ann Thorac Surg 85(1):319–321CrossRefPubMed Knott-Craig CJ, Goldberg SP (2008) Emergent surgical retrieval of embolized atrial septal defect closure device. Ann Thorac Surg 85(1):319–321CrossRefPubMed
Metadaten
Titel
Safety, Feasibility, Results, and Economic Impact of Common Interventional Procedures in a Low-Volume Region of the United States
verfasst von
Aaron Clem
Sami Awadallah
Zahid Amin
Publikationsdatum
21.06.2017
Verlag
Springer US
Erschienen in
Pediatric Cardiology / Ausgabe 7/2017
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-017-1664-z

Weitere Artikel der Ausgabe 7/2017

Pediatric Cardiology 7/2017 Zur Ausgabe

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Komplette Revaskularisation bei Infarkt: Neue Studie setzt ein Fragezeichen

24.04.2024 ACC 2024 Nachrichten

Eine FFR-gesteuerte komplette Revaskularisation war in einer Studie bei Patienten mit akutem Myokardinfarkt und koronarer Mehrgefäßerkrankung klinisch nicht wirksamer als eine alleinige Revaskularisation der Infarktarterie.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.